$133.18
1.641.25%
At Close: -
$133.38
0.20.15%
After Hours: 5:12 PM EDT
15 minutes delayed
Comments
Loading...
Novo Nordisk
NVONYSE
Latest news for Novo Nordisk (NYSE:NVO) Stock
Novo Nordisk Stock (NYSE: NVO)
Categories: All
Monday, July 22, 2024
Friday, July 19, 2024
Thursday, July 18, 2024
- EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
- VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday?
- Shares of weight loss stocks are trading lowe...
Wednesday, July 17, 2024
- Novo Nordisk Faces Setback in Netherlands Over Wegovy Insurance Coverage
- Pfizer And Roche Advance On Their Weight Loss Drug Journeys
- Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?
- $1000 Invested In Novo Nordisk 10 Years Ago Would Be Worth This Much Today
- Benzinga Market Summary: Chip Stocks Fall On ...
- Eli Lilly and Novo Nordisk shares are trading...
Tuesday, July 16, 2024
Monday, July 15, 2024
Friday, July 12, 2024
Thursday, July 11, 2024
- Eli Lilly, Novo Nordisk Shares Dip As Pfizer Ramps Up Diabetes Drug Competition
- Bernie Sanders Targets High Prices of Ozempic and Wegovy In US
- Shares of Lilly and Novo Nordisk are trading ...
- FDA Rejects Novo Nordisk's Weekly Insulin, Requests Information Related To Manufacturing Process, Type 1 Diabetes
- EXCLUSIVE: Vivani Medical Outlines Plans To Kickstart First Clinical Study For Miniature GLP-1 Obesity Implant Program This Year
- Wednesday, The FDA Issued A Complete Response...
- Jim Cramer Identifies Eight Companies Eyeing Trillion-Dollar Club — Elon Musk's Tesla, Eli Lilly Top Contenders
Wednesday, July 10, 2024
Tuesday, July 09, 2024
Monday, July 08, 2024
Sunday, July 07, 2024
Friday, July 05, 2024
Thursday, July 04, 2024
Wednesday, July 03, 2024
- S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
- Using Obesity Drugs? Potential Vision Loss Disorder Linked To Novo Nordisk's Ozempic And Wegovy, Study Finds
- Novo Nordisk and Lilly shares are trading low...
- Novo Nordisk Shares See Further Drop; 'Study ...
- 'Potential Link Between Ozempic, Wegovy And S...